Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo-Controlled Trial
Authors:
- Stanley E. GraberSGStanley E. Graber
- Sanford B. KrantzSKSanford B. Krantz
- Emmanuel N. DessyprisEDEmmanuel N. Dessypris
- Vicki L. O’neilVOVicki L. O’neil
- Nancy J. OlsenNONancy J. Olsen
- Theodore P. PincusTPTheodore P. Pincus
- 1 September 1988
- journal article
- clinical trial
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 296 (3) , 171-179
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Suppression of maturation of megakaryocyte colony forming unit in vitro by a platelet‐released glycoproteinJournal of Cellular Physiology, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985
- Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiencyKidney International, 1984
- Increased Sensitivity to Complement of Erythroid and Myeloid Progenitors in Paroxysmal Nocturnal HemoglobinuriaNew England Journal of Medicine, 1983
- Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of childrenBlood, 1982
- Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal functionBlood, 1979
- Apparently spontaneous chromosome damage in human leukocytes and the nature of chromatid gaps1971
- Studies on Erythropoiesis. Part IV. Reticulocyte Response of Hypophysectomized and Polycythemic Rodents to ErythropoietinExperimental Biology and Medicine, 1957